Fifth Third Bancorp Editas Medicine, Inc. Transaction History

Fifth Third Bancorp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$9.99 - $21.35 $1,998 - $4,270	200 New	200 $2,000
Q1 2022 Apr 19, 2022	SELL	$14.08 - $27.63 $2,816 - $5,526	-200 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$26.55 - $40.57 $3,584 - $5,476	135 Added 207.69%	200 $5,000
Q3 2021 Oct 15, 2021	BUY	$39.27 - $72.94 $2,552 - $4,741	65 New	65 $3,000
Q1 2019 May 14, 2019	SELL	$19.43 - $26.41 $38 - $52	-2 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $36 - $63	2 New	2 $0
Q3 2018 Nov 14, 2018	SELL	$27.65 - $38.39 $3,456 - $4,798	-125 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$31.4 - $41.01 $3,925 - $5,126	125 New	125 $4,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.